Highlights from Eton Pharmaceuticals' Upcoming Presentation
Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a company dedicated to developing and commercializing cutting-edge treatments for rare diseases, is gearing up for an important engagement at the highly anticipated Piper Sandler 37th Annual Healthcare Conference. This event is an opportunity for the Company to showcase its commitment to innovation within the pharmaceutical industry.
Event Details
During the conference, members of Eton’s executive leadership team will participate in an engaging fireside chat. Attendees will have the chance to learn more about the Company’s pipeline and commitment to providing solutions for rare diseases.
Date and Time
The presentation is scheduled for a Thursday morning slot, occurring at 9:30 AM ET. This timing allows industry professionals to gather insights and engage in meaningful discussions.
Location
The event will take place at the prestigious Lotte New York Palace, providing an excellent backdrop for the exchange of ideas amongst healthcare stakeholders.
About Eton Pharmaceuticals
Eton Pharmaceuticals is renowned for its focus on rare diseases. The Company has successfully brought to market eight distinct products including KHINDIVI™, INCRELEX, ALKINDI SPRINKLE, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. Each of these therapeutics plays a vital role in managing complex health conditions.
Additionally, Eton has a robust pipeline, featuring five product candidates in the final stages of development. These include ET-600, Amglidia, ET-700, ET-800, and the ZENEO hydrocortisone autoinjector. This proactive approach highlights Eton's dedication to advancing healthcare for patients facing rare diseases.
Connecting with Eton
For those interested in deeper conversations, Eton Pharmaceuticals encourages scheduling one-on-one meetings through Piper Sandler's institutional sales representatives. This engagement enhances connectivity and insight sharing between the Company and industry professionals.
Investor Relations Contact
For investor inquiries, Eton Pharmaceuticals has made Lisa M. Wilson from In-Site Communications, Inc. available. Prospective investors may reach her at 212-452-2793 or via email at lwilson@insitecony.com.
Frequently Asked Questions
What is Eton Pharmaceuticals known for?
Eton Pharmaceuticals is known for developing and commercializing treatments for rare diseases.
What products does Eton currently offer?
Eton has eight commercial rare disease products, including KHINDIVI™ and INCRELEX.
When will Eton present at the healthcare conference?
Eton will present on Thursday at 9:30 AM ET during the Piper Sandler conference.
How can I schedule a meeting with Eton?
Interested individuals can schedule meetings through their Piper Sandler institutional sales representative.
Who can I contact for investor relations at Eton?
Lisa M. Wilson from In-Site Communications, Inc. handles investor relations for Eton Pharmaceuticals.